Shin Nippon Biomedical Laboratories, Ltd.
Symbole: 2395.T
JPX
1382
JPYPrix du marché aujourd'hui
10.4018
Ratio P/E
-0.0850
Ratio PEG
57.54B
Cap MRK
- 0.04%
Rendement DIV
Shin Nippon Biomedical Laboratories, Ltd. (2395-T) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 49530.68 | 10611.5 | 10533.1 | 6997 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 3145 | 336.7 | -423.6 | 368.1 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 20683.56 | 5722.8 | 4760.4 | 3501.6 | ||||||||||||||||||||
balance-sheet.row.inventory | 42637.06 | 12373.2 | 7329.4 | 4359.4 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 10019.12 | 2130.2 | 1276.7 | 1276.5 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 122870.42 | 30837.7 | 23899.6 | 16134.5 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 88977 | 26357.7 | 18879.3 | 13155.8 | ||||||||||||||||||||
balance-sheet.row.goodwill | 7869.39 | 1934.4 | 1438.8 | 0.3 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 1050.12 | 224.9 | 260.7 | 212 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 8919.51 | 2159.3 | 1699.4 | 212.3 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 51980.39 | 15254.6 | 12404 | 8645 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 1713.37 | 990 | 325.8 | 1129.6 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 4386.87 | 703.1 | 34.2 | 35.4 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 155977.14 | 45464.6 | 33342.6 | 23178.2 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 278847.56 | 76302.3 | 57242.2 | 39312.7 | ||||||||||||||||||||
balance-sheet.row.account-payables | 1981.7 | 460.5 | 419.8 | 64.6 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 30435 | 7826.2 | 8923.2 | 2942.7 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 3945.81 | 1701.1 | 603.7 | 743.1 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 67029.12 | 18147.9 | 9837.5 | 6195.6 | ||||||||||||||||||||
Deferred Revenue Non Current | 212.81 | 212.8 | -1064 | -68.2 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 84.94 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 22704.08 | 13580.1 | 3009.8 | 2685.1 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 67911.4 | 18573.8 | 9871.5 | 6215.6 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 1051.9 | 212.8 | 357 | 385.8 | ||||||||||||||||||||
balance-sheet.row.total-liab | 155974.04 | 42141.7 | 30883.2 | 19589.5 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 2620.8 | ||||||||||||||||||||
balance-sheet.row.common-stock | 38716.28 | 9679.1 | 9679.1 | 9679.1 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 62069.02 | 17215.8 | 13766.2 | 10196.3 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 12355.19 | 4861.4 | 460.2 | -2620.8 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 9378.15 | 2358.1 | 2306.4 | -314.3 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 122518.64 | 34114.4 | 26211.8 | 19561.1 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 278847.56 | 76302.3 | 57242.2 | 39312.7 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 354.88 | 46.2 | 147.2 | 162 | ||||||||||||||||||||
balance-sheet.row.total-equity | 122873.52 | 34160.6 | 26359 | 19723.1 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 278847.56 | - | - | - | ||||||||||||||||||||
Total Investments | 53040.48 | 15591.3 | 11980.4 | 7080.1 | ||||||||||||||||||||
balance-sheet.row.total-debt | 97676.93 | 26186.9 | 18760.7 | 9138.3 | ||||||||||||||||||||
balance-sheet.row.net-debt | 51291.25 | 15912.1 | 8227.6 | 2509.4 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 5530.61 | 7759.6 | 8183.3 | 4175.6 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 1330.2 | 1600.5 | 1177.4 | 1187.7 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2812.9 | 723.3 | 532 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -937 | -480 | -343 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -968.5 | -371.1 | -71.7 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | -268.2 | -36.7 | -24.2 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -639.2 | 1611.1 | 970.8 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | -5530.61 | -2543.2 | -4131.3 | -1148.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 2660.4 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -1937.2 | 1200.8 | 1242.3 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -1514.3 | -4194.1 | -895 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2532.2 | 266.7 | 91.4 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -55.5 | 72.3 | 410.6 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -5930.6 | -4268.5 | -268.7 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -5468.1 | -3492.3 | -4598.2 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.2 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2484.4 | -826.5 | -206.2 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 14218.8 | -593.1 | 2333.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 6266.2 | -4912 | -2471.1 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 311.5 | 496.7 | 29.6 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 3581.63 | 4648.9 | -2731 | 2036.6 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 34615.1 | 9197.7 | 4548.8 | 7279.8 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 31033.48 | 4548.8 | 7279.8 | 5243.3 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 2660.4 | 4004 | 5952.8 | 4746.7 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -4955.7 | -1614.3 | -1118 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 2660.4 | -951.7 | 4338.5 | 3628.7 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 26450.47 | 26450.5 | 25090.9 | 17748.5 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 12429.26 | 12429.3 | 12044.2 | 8061.2 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 14021.21 | 14021.2 | 13046.7 | 9687.3 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 1741.19 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 387.97 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1566.33 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | -60.2 | 0 | 15.2 | 191.1 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 10120.22 | 9858.8 | 7801.4 | 5491.7 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 22549.48 | 22288.1 | 19845.7 | 13552.9 | ||||||||||||||||||||
income-statement-row.row.interest-income | 186.56 | 186.6 | 57.4 | 8.3 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 138.78 | 138.8 | 125.1 | 126.6 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1566.33 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 3072.17 | 2812.1 | 2514 | 3986 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -60.2 | 0 | 15.2 | 191.1 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 3072.17 | 2812.1 | 2514 | 3986 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 138.78 | 138.8 | 125.1 | 126.6 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 2695.93 | 1868 | 1600.5 | 1177.4 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 6884.16 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 3900.99 | 4162.4 | 5245.2 | 4195.6 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 6974.44 | 6974.4 | 7759.6 | 8183.3 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 1456.74 | 1456.7 | 1708.9 | 1016.2 | ||||||||||||||||||||
income-statement-row.row.net-income | 5531.26 | 5531.3 | 6060.1 | 7127.6 |
Questions fréquemment posées
Quel est le total de Shin Nippon Biomedical Laboratories, Ltd. (2395.T) de l'actif total?
Shin Nippon Biomedical Laboratories, Ltd. (2395.T) Le total des actifs est 76302347000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 14566421000.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.530.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 63.903.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.209.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.147.
Qu'est-ce que Shin Nippon Biomedical Laboratories, Ltd. (2395.T) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 5531261000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 26186858000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 9858847000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 10274773000.000.